Who Paid My Doc
Trinav Infusion System
Device Oncology
PDI 00857136004217
General payments
$3,896,658
Research payments
$9,228,557
Through program year 2025, $3,896,658 in general payments and $9,228,557 in research payments were reported against Trinav Infusion System (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,378,716 | 3,096 |
| 2025 | Research | $2,394,304 | 61 |
| 2024 | General | $443,261 | 2,429 |
| 2024 | Research | $4,330,490 | 292 |
| 2023 | General | $1,173,355 | 2,515 |
| 2023 | Research | $1,205,965 | 87 |
| 2022 | General | $701,899 | 1,112 |
| 2022 | Research | $750,375 | 31 |
| 2021 | General | $199,427 | 479 |
| 2021 | Research | $547,424 | 14 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 57 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,631 general · 485 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.